Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses. (Q46421937)
Jump to navigation
Jump to search
scientific article published on 4 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses. |
scientific article published on 4 April 2014 |
Statements
Intralesional treatment of stage III metastatic melanoma patients with L19-IL2 results in sustained clinical and systemic immunologic responses (English)
Graham Pawelec
Jürgen C Becker
Benjamin Weide
Annette Pflugfelder
Leonardo Giovannoni
Pier Adelchi Ruffini
Henning Zelba
Alexander Martens
1 reference